Form 8-K - Current report:
SEC Accession No. 0001558370-24-014526
Filing Date
2024-11-06
Accepted
2024-11-06 07:45:20
Documents
16
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elev-20241106x8k.htm   iXBRL 8-K 43153
2 EX-99.1 elev-20241106xex99d1.htm EX-99.1 89057
  Complete submission text file 0001558370-24-014526.txt   276253

Data Files

Seq Description Document Type Size
3 EX-101.SCH elev-20241106.xsd EX-101.SCH 3967
4 EX-101.DEF elev-20241106_def.xml EX-101.DEF 2823
5 EX-101.LAB elev-20241106_lab.xml EX-101.LAB 17919
6 EX-101.PRE elev-20241106_pre.xml EX-101.PRE 11887
19 EXTRACTED XBRL INSTANCE DOCUMENT elev-20241106x8k_htm.xml XML 5040
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 241429268
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)